Anzeige
Mehr »
Donnerstag, 16.07.2026 - Börsentäglich über 12.000 News
Warum sollte ein $1-Mrd.-Uranriese 15,6 % an einem Explorer zu 0,10 CAD kaufen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40X1Q | ISIN: SE0023261599 | Ticker-Symbol: E0C
Frankfurt
15.07.26 | 08:06
2,110 Euro
-0,47 % -0,010
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
CARASENT AB Chart 1 Jahr
5-Tage-Chart
CARASENT AB 5-Tage-Chart
RealtimeGeldBriefZeit
2,1302,33015.07.

Aktuelle News zur CARASENT Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrCarasent Q2 2026 slides: ARR hits SEK 401m, margins expand to 19%1
FrCarasent AB: Carasent AB (publ) - interim report Q2 202656Q2 2026 highlightsNet sales amounted to SEK 97.7 (82.9) million, corresponding to a net sales growth of 18%.Organic growth amounted to 11% at constant currency.EBITDA amounted to SEK 14.8 (12.1) million...
► Artikel lesen
CARASENT Aktie jetzt für 0€ handeln
09.06.Carasent AB: Carasent completes the acquisition of Infosolutions143Carasent has today completed the acquisition of Infosolutions Sverige AB, including its wholly-owned subsidiaries, which was announced on 27 April 2026. The purchase price amounted to SEK 128 million...
► Artikel lesen
27.04.Carasent AB: Carasent acquires Infosolutions and strengthens its position in Swedish private healthcare297Carasent has today committed to acquire Infosolutions Sverige AB, including its wholly-owned subsidiaries ("Infosolutions"), which is a key player in connecting EHR systems with other actors in the...
► Artikel lesen
14.04.Carasent AB: Carasent AB (publ) - Interim Report Q1 2026142Q1 2026 highlightsNet sales amounted to MSEK 90.4 MSEK (85.2), corresponding to a net sales growth of 6%. Organic growth amounted to 7% at constant currency. EBITDA amounted to MSEK 18.3 (13.9), corresponding...
► Artikel lesen
12.02.Carasent AB: Carasent AB (publ) - Year-end report January-December 2025192Q4 2025 highlightsNet sales amounted to MSEK 93.6 (78.7), corresponding to a net sales growth of 19%.Organic growth amounted to 16%, while net acquisitions and divestments in the last twelve months...
► Artikel lesen
16.10.25Carasent AB: Carasent AB (publ) - Interim report January-September 2025210Q3 2025 highlightsNet sales amounted to MSEK 82.2 (64.5), corresponding to a net sales growth of 27%.Organic growth was 13%, while net acquisitions and divestments in the last twelve months accounted...
► Artikel lesen
7 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1